Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Cancers|May 28, 2022
Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck CancerJulie E Bauman, Ricklie Julian, Nabil F Saba, et al.
Communications Biology|March 27, 2019
Dynamic host immune response in virus-associated cancersSong Cao, Kristine M Wylie, Matt A Wyczalkowski, et al.
The Laryngoscope|December 24, 2016
Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 diseaseJoseph Zenga, Bruce H Haughey, Ryan S Jackson, et al.
Cell Reports|August 23, 2018
Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular HeterogeneityKatie M Campbell, Tianxiang Lin, Paul Zolkind, et al.
Cancer|September 8, 2017
Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsilRe-I Chin, Yuan James Rao, Michael Y Hwang, et al.
Cell Death & Disease|October 14, 2016
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomasGregory R Bean, Jeff C Kremer, Bethany C Prudner, et al.
Oral Oncology|June 3, 2020
Duration of radiation therapy is associated with worse survival in head and neck cancerAngela L Mazul, Katelyn O Stepan, Thomas F Barrett, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 19, 2025
Long-Term Outcomes After Elective Contralateral Neck Dissection for HPV-Related Oropharyngeal CancerRay Y Wang, Molly E Heft Neal, Wade L Thorstad, et al.
Rare Tumors|October 14, 2021
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcomaBrian A Van Tine, Mia C Weiss, Angela C Hirbe, et al.
Future Oncology (London, England)|November 8, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib studyLyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.
Pageof 14